Citric Acid

Citric Acid

SCHEMBL1065771

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Ca+2].[Na+]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CA4 P22748 4/20 0.94
CASP1 P29466 1/20 0.36
FFAR3 O14843 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CA2 P00918 1/20 0.31
FAHD1 Q6P587 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL15173183 1.00 CA4 (0.94) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL447074 0.97 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL28025182 0.97 CA4 (0.90) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL2235356 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL715802 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL29775 0.97 CA4 (0.89) CA4CASP1ALDH1A1
Citric Acid SCHEMBL276988 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL3657 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1
Citric Acid SCHEMBL8845344 0.97 CA4 (0.89) CA4CASP1ALDH1A1
Citric Acid SCHEMBL11060179 0.97 CA4 (1.00) CA4CASP1FFAR3HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108002840-A A kind of biology implantation ceramic material and preparation method 明光市裕阳新材料有限公司 2018-05-08 CN claimed
WO-2000077242-A2 DETECTION OF MICROORGANISMS INTERNATIONAL DIAGNOSTICS GROUP PLC (GB) 2000-12-21 WO claimed
JP-8040975-A None JP disclosed
CN-111134334-B Probiotics microcapsule soft particles and preparation method thereof 内蒙古蒙牛乳业(集团)股份有限公司 2023-08-29 CN disclosed
US-20220395466-A1 MICROCAPSULE, PREPARATION METHOD AND APPLICATION THEREOF Inner Mongolia Mengniu Dairy (group) Co., Ltd. (CN) 2022-12-15 US disclosed
EP-4042881-A1 MICROCAPSULE, PREPARATION METHOD AND APPLICATION THEREOF INNER MONGOLIA MENGNIU DAIRY (GROUP) CO., LTD. (CN) 2022-08-17 EP disclosed
US-11272725-B2 Low methoxyl pectin from jelly fig and method for producing the same HOU SHIH KUO (TW) 2022-03-15 US disclosed
US-20210068435-A1 LOW METHOXYL PECTIN FROM JELLY FIG AND METHOD FOR PRODUCING THE SAME HOU SHIH KUO (TW) 2021-03-11 US disclosed
CN-109430251-A A kind of store method of the preservation liquid of adipose tissue and preparation method thereof with adipose tissue 广州康琪莱生物科技有限公司 2019-03-08 CN disclosed
CN-108002840-A A kind of biology implantation ceramic material and preparation method 明光市裕阳新材料有限公司 2018-05-08 CN disclosed
CN-108002840-A A kind of biology implantation ceramic material and preparation method 明光市裕阳新材料有限公司 2018-05-08 CN disclosed
EP-1429630-A1 PROCESS FOR THE FORTIFICATION OF A FRUIT BASED FOOD PRODUCT WITH CALCIUM Purac Biochem B.V. (NL) 2004-06-23 EP disclosed
WO-2003024250-A1 PROCESS FOR THE FORTIFICATION OF A FRUIT BASED FOOD PRODUCT WITH CALCIUM PURAC BIOCHEM B.V. (NL) 2003-03-27 WO disclosed
US-20030059499-A1 Process for the fortification of a fruit based food product with calcium PURAC BIOCHEM B.V. (NL) 2003-03-27 US disclosed
EP-1295536-A1 Process for the fortification of a fruit based food product with calcium Purac Biochem B.V. (NL) 2003-03-26 EP disclosed
CN-1345925-A Method for preventing non-biological haze and settling in yellow rice wine and clear wine WANG MEIZHI (CN) 2002-04-24 CN disclosed
CN-1323881-A Method of preventing non-biogenic turbidity and precipitate in yellow wine WANG MEIZHI (CN) 2001-11-28 CN disclosed
CN-1323882-A Method of preventing non-biogenic turbidity and precipitate in yellow wine WANG MEIZHI (CN) 2001-11-28 CN disclosed
JP-H0840975-A CALCIUM-ALKALI METAL CITRIC SALT COMPOUND, ITS PRODUCTION AND MEDICINE CONTAINING THE SAME MADAUS AG 1996-02-13 JP disclosed
US-4170590-A Ion exchanger treatment of citrate-stabilized plasma BIOTEST-SERUM-INSTITUT GMBH (DE) 1979-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220395466-A1 MICROCAPSULE, PREPARATION METHOD AND APPLICATION THEREOF CEL, MBOAT4, MLN CA4 1514/4885CASP1 314/4885FFAR3 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.